abs104.txt	the	clinical	sequencing	evidence-generating	research	(cser)	consortium		now	inits	second	funding	cycle	is	investigating	effectiveness	of	integratinggenomic	(exome	or	genome)	into	care	diverse	andmedically	underserved	individuals	in	a	variety	healthcare	settings	and	diseasestates	comprises	coordinating	center	six	funded	extramuralclinical	projects	an	ongoing	national	human	genome	institute(nhgri)	intramural	project	collectively	these	aim	to	enroll	andsequence	over	6	100	participants	four	years	at	least	60%	willbe	non-european	ancestry	from	with	goal	ofdiversifying	populations	that	are	providing	evidence	base	for	genomicmedicine	five	enrolling	pediatric	patients	withvarious	phenotypes	one	also	couples	whosefetus	has	structural	anomaly	sixth	adults	riskfor	hereditary	cancer	nhgri	enrolledprimarily	healthy	goals	include	assessing	clinicalutility	genomic	exploring	medical	follow	up	cascade	testing	ofrelatives	evaluating	patient-provider-laboratory	level	interactions	thatinfluence	use	this	technology	findings	cser	willoffer	systems	policymakers	clearer	understanding	ofthe	opportunities	challenges	medicine	diversepopulations	contribute	toward	developing	bestpractices	delivery	clinically	useful	cost-effective	genomicsequencing
